Anti-Human CD38 Recombinant Antibody(Daratumumab)

Name: Anti-Human CD38 Recombinant Antibody(Daratumumab)
Brand: KMD Bioscience
SKU: YR1199

YR1199

科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab

DATASHEET MSDS

Product Description

Alias	科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab
Catalog Number	YR1199
Molecular Name	Daratumumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.
CAS Number	945721-28-8
Application	WB, IP, IF, FuncS, FCM, Neut, ELISA
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	148 kDa
Target	CD38[Homo sapiens]

Login